back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-12-13 14:57 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+62,100 vol |
90,300 | |
| Filed 2023-12-13 14:57 Tx date 2023-12-08 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$442,547
+231,700 vol $1.91 each |
1,098,962 | |
| Filed 2023-11-20 10:22 Tx date 2023-11-19 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,000 vol |
867,262 | |
| Filed 2023-08-18 11:43 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+28,200 vol |
28,200 | |
| Filed 2023-08-18 11:41 Tx date 2023-08-15 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$289,800
+105,000 vol $2.76 each |
920,262 | |
| Filed 2022-12-19 10:40 Tx date 2022-12-17 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-4,210 vol |
815,262 | |
| Filed 2022-12-13 12:42 Tx date 2022-12-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$184,800
+80,000 vol $2.31 each |
819,472 | |
| Filed 2022-11-14 15:29 Tx date 2022-11-13 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-21,052 vol |
739,472 | |
| Filed 2022-06-16 09:40 Tx date 2022-06-15 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,340
+6,000 vol $0.89 each |
45,028 | |
| Filed 2022-06-14 16:00 Tx date 2022-06-14 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,160
+6,000 vol $0.86 each |
39,028 | |
| Filed 2022-03-09 10:13 Tx date 2022-03-08 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-442,414.05
-59,705 vol $7.41 each |
760,524 | |
| Filed 2021-12-15 09:48 Tx date 2021-12-14 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,684 vol |
820,229 | |
| Filed 2021-12-13 17:34 Tx date 2021-12-10 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,400
+55,000 vol $2.08 each |
823,913 | |
| Filed 2021-03-12 19:14 Tx date 2021-03-12 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+22,105 vol |
33,028 | |
| Filed 2021-03-12 19:13 Tx date 2021-03-12 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
57 - Exercise of rights
|
-22,105 vol |
0 | |
| Filed 2021-03-12 18:15 Tx date 2021-03-08 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$527,000
+155,000 vol $3.40 each |
768,913 | |
| Filed 2021-02-14 16:40 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-167,963.04
-2,631 vol $63.84 each |
613,913 | |
| Filed 2020-12-15 10:13 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-167,963.04
-2,631 vol $63.84 each |
||
| Filed 2020-12-16 16:57 Tx date 2020-12-11 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$792,500
+250,000 vol $3.17 each |
616,544 | |
| Filed 2020-12-15 10:13 Tx date 2020-12-14 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-167,963.04
-2,631 vol $63.84 each |
363,913 | |
| Filed 2020-03-09 10:19 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,250
+125,000 vol $1.45 each |
366,544 | |
| Filed 2019-12-18 15:35 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,250
+125,000 vol $1.45 each |
||
| Filed 2019-12-18 15:35 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$181,250
+125,000 vol $1.45 each |
366,544 | |
| Filed 2019-12-09 10:17 Tx date 2019-12-08 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-30,581.64
-1,052 vol $29.07 each |
241,544 | |
| Filed 2019-06-18 15:35 Tx date 2019-06-18 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,370
+1,500 vol $2.25 each |
10,923 | |
| Filed 2018-12-22 Tx date 2018-12-21 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,007
+1,250 vol $2.41 each |
9,423 | |
| Filed 2018-12-12 Tx date 2018-12-11 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,275
+4,100 vol $2.75 each |
8,173 | |
| Filed 2018-11-23 Tx date 2018-11-19 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$182,320
+53,000 vol $3.44 each |
242,596 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-34,627 vol |
4,073 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
37 - Stock split or consolidation
|
-187,895 vol |
22,105 | |
| Filed 2018-11-23 Tx date 2018-05-22 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,611,604 vol |
189,596 | |
| Filed 2018-03-16 Tx date 2018-03-15 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$442,416
+567,200 vol $0.78 each |
1,801,200 | |
| Filed 2017-12-13 Tx date 2017-12-12 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-19,980
-9,000 vol $2.22 each |
1,234,000 | |
| Filed 2017-01-19 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+210,000 vol |
||
| Filed 2017-01-19 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
56 - Grant of rights
|
+210,000 vol |
210,000 | |
| Filed 2017-01-19 Tx date 2012-11-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-01-19 Tx date 2017-01-18 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-10,575
-4,700 vol $2.25 each |
1,243,000 | |
| Filed 2017-01-19 Tx date 2017-01-16 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$84,000
+300,000 vol $0.28 each |
1,247,700 | |
| Filed 2016-09-13 Tx date 2016-09-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+210,000 vol |
210,000 | |
| Filed 2016-09-13 Tx date 2012-11-09 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-02 Tx date 2015-12-01 |
$ONC
Oncolytics Biotech Inc. |
Look, Kirk
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$194,880
+464,000 vol $0.42 each |
947,700 |